Close
CDMO Safety Testing 2026
Novotech

Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical & Biotech Industry

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

AddParts Secures Funding for Pharma Manufacturing Resilience

AddParts, a UK-based technology company focused on improving operational...

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...
- Advertisement -

Veranova and Phorum.AI announced that they are collaborating on next-generation optimization of pharmaceutical manufacturing processes using artificial intelligence (AI)

Building on years of research and experimentation by Phorum.AI co-founder and MIT Professor of Chemistry, Brad Pentelute, Phorum.AI is deploying generative AI systems to help biopharmaceutical companies rapidly develop optimized manufacturing processes that can reduce costs, speed development timelines, and reduce environmental footprint.

The parties will leverage Veranovaโ€™s extensive empirical manufacturing dataset, developed over 20 years of manufacturing a portfolio of owned active pharmaceutical ingredient (API) drug master files (DMFs), and Phorum.AIโ€™s market-leading expertise in generative AI to develop a tool that will enable development of optimized manufacturing processes in a fraction of the time versus historical methods.

โ€œPhorum.AI and Veranova have the potential to create a step change in the quality and development efficiency of pharmaceutical processingโ€, said Mike Riley, CEO of Veranova. โ€œWe are delighted to partner with a leading AI technology innovator to be able to offer our clients a new capability that has the potential to develop optimized manufacturing processes at an accelerated pace.โ€

Phorum.AI, founded in 2023 by Pentelute and David Shrier, CEO of venture studio Visionary Future LLC, has already developed a functional computational chemistry engine that is producing real-world optimization of pharmaceutical manufacturing, building on a proprietary AI model, data set, and data factory.

โ€œBy partnering with Veranova, a worldwide leader in developing and manufacturing APIs, we are able to more rapidly scale our market footprint and create greater impact soonerโ€, Dan Chinnapen, CEO of Phorum.AI, adding โ€œWe are excited to reduce time to market and mitigate costs for much-needed therapeuticsโ€.

The two companies are collaborating on a commercial partnership that enables Veranova clients to benefit from an integrated scale-up solution powered by Phorum.AIโ€™s technology.

Latest stories

Related stories

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

AddParts Secures Funding for Pharma Manufacturing Resilience

AddParts, a UK-based technology company focused on improving operational...

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป